A Novel Aldosterone Antagonist Limits Renal Injury in 5/6 Nephrectomy
Abstract Aldosterone antagonists slow the progression of chronic kidney disease (CKD), but their use is limited by hyperkalemia, especially when associated with RAS inhibitors. We examined the renoprotective effects of Ly, a novel non-steroidal mineralocorticoid receptor (MR) blocker, through two ex...
Guardado en:
Autores principales: | Clarice K. Fujihara, M. C. Kowala, M. D. Breyer, Claudia R. Sena, Mariliza V. Rodrigues, Simone C. A. Arias, Camilla Fanelli, Denise M. Malheiros, P. K. Jadhav, Chahrzad Montrose-Rafizadeh, Jose E. Krieger, Roberto Zatz |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/780f96a202214d06a07005c8f676b540 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Innate And Adaptive Immunity are Progressively Activated in Parallel with Renal Injury in the 5/6 Renal Ablation Model
por: Camilla Fanelli, et al.
Publicado: (2017) -
[85] Laparoscopic donor nephrectomy
por: Abraham Vinod Peedikayil
Publicado: (2018) -
Aldosterone Modulates the Association between NCC and ENaC
por: Brandi M. Wynne, et al.
Publicado: (2017) -
Circulating microRNAs as Diagnostic Markers in Primary Aldosteronism
por: Scott M. MacKenzie, et al.
Publicado: (2021) -
Transcriptomics, Epigenetics, and Metabolomics of Primary Aldosteronism
por: Ariadni Spyroglou, et al.
Publicado: (2021)